RxDoctor Payments Data

Deborah Wiles, NP

Family · Murray, KYNPI 1740459247

Payments from drug & device makers

$1,218in general payments, 2019–2025

Across 64 payments — averaging $19.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$253
  • Astellas Pharma US Inc$246
  • Lilly USA, LLC$118
  • Novo Nordisk$107
  • Amgen$84
  • AstraZeneca$61
  • plus $348 from 14 others

What the payments were for

  • Food & beverage$1,03885%
  • Education$18015%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,218 in reported general payments places this provider in the 65th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$40,098
Medicare patients
118
Services billed
1,031

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide30$49,124
RybelsusSemaglutide26$36,997
MounjaroTirzepatide17$17,308
Xigduo XrDapaglifloz Propaned/Metformin12$14,650
EliquisApixaban11$10,793
Lantus SolostarInsulin Glargine,hum.Rec.Anlog31$3,252
Duloxetine Hcl48$3,005
SynthroidLevothyroxine Sodium31$1,797
Metoprolol Succinate102$1,270
Pantoprazole Sodium99$1,212
Losartan Potassium162$1,199
Vilazodone Hcl13$1,053
Levothyroxine Sodium102$995
Montelukast Sodium105$959
Estradiol (Twice Weekly)Estradiol12$911

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$107$86,12156 claims
Lilly USA, LLCMounjaro$118$17,30817 claims
AbbVieSynthroid$253$1,79731 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 4,374 family providers in Kentucky.

Other family in Murray

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →